SynthesisScientific reports2021
Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases.
Synthesis in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Non-COVID-19 mortality among older people or with chronic conditions during year 2020 in France: a nationwide cohort study.BMC public health · 2025Article
- Impact of the COVID-19 pandemic on admissions of deceased to an institute of legal medicine in Germany.Scientific reports · 2025Article
- Concordance between MITS and conventional autopsies for pathological and virological diagnoses.International journal of legal medicine · 2024Article
- Unveiling the Pathological Mechanisms of Death Induced by SARS-CoV-2 Viral Pneumonia.Microorganisms · 2024Article
- COVID-19 mortality sentinel surveillance at a tertiary referral hospital in Lusaka, Zambia, 2020-2021.PLOS global public health · 2024Article
- Minimally Invasive Tissue Sampling via Post Mortem Ultrasound: A Feasible Tool (Not Only) in Infectious Diseases-A Case Report.Diagnostics (Basel, Switzerland) · 2023Article
- Review
- Viable SARS-CoV-2 Omicron sub-variants isolated from autopsy tissues.Frontiers in microbiology · 2023Article
- [One and a half years of e-scooters in Hamburg].Rechtsmedizin (Berlin, Germany) · 2023Article
- The Effects of SARS-CoV-2 Virus Type and of Vaccination Status on Causes of Death Over the Course of the COVID-19 Pandemic.Deutsches Arzteblatt international · 2022Article
- Guillain-Barré syndrome as a fatal complication of SARS-CoV-2 infection - An autopsy case.Legal medicine (Tokyo, Japan) · 2022Article
- COVID-19 coagulopathy - what should we treat?Experimental physiology · 2022Review
- Article
- First report from the German COVID-19 autopsy registry.The Lancet regional health. Europe · 2022Article
- Tracheal Aspirate Galactomannan Testing in COVID-19-Associated Pulmonary Aspergillosis.Frontiers in fungal biology · 2022Article
- Young COVID-19 Patients Show a Higher Degree of Microglial Activation When Compared to Controls.Frontiers in neurology · 2022Article
- Is endocan correlated to ARDS severity or an epiphenomenon of thrombo-embolic disease in COVID.Critical care (London, England) · 2021Article
- Mortality of Patients Infected by COVID-19 with and without Deep-Vein Thrombosis.Medicines (Basel, Switzerland) · 2021Article
Corrections and comments
- Commented on by
Authors and funding
34 authors.
Funding
Abstract
Coronavirus disease 19 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic with significant mortality. Accurate information on the specific circumstances of death and whether patients died from or with SARS-CoV-2 is scarce. To distinguish COVID-19 from non-COVID-19 deaths, we performed a systematic review of 735 SARS-CoV-2-associated deaths in Hamburg, Germany, from March to December 2020, using conventional autopsy, ultrasound-guided minimally invasive autopsy, postmortem computed tomography and medical records. Statistical analyses including multiple logistic regression were used to compare both cohorts. 84.1% (n = 618) were classified as COVID-19 deaths, 6.4% (n = 47) as non-COVID-19 deaths, 9.5% (n = 70) remained unclear. Median age of COVID-19 deaths was 83.0 years, 54.4% were male. In the autopsy group (n = 283), the majority died of pneumonia and/or diffuse alveolar damage (73.6%; n = 187). Thromboses were found in 39.2% (n = 62/158 cases), pulmonary embolism in 22.1% (n = 56/253 cases). In 2020, annual mortality in Hamburg was about 5.5% higher than in the previous 20 years, of which 3.4% (n = 618) represented COVID-19 deaths. Our study highlights the need for mortality surveillance and postmortem examinations. The vast majority of individuals who died directly from SARS-CoV-2 infection were of advanced age and had multiple comorbidities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.